Purple Biotech's market cap is currently 19.87M. The company's EPS TTM is -0.7000000000000001; its P/E ratio is ―; Purple Biotech is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
